Alencar H

No ORCID on file · 1 paper in corpus · active 2008
2008
PLoS medicine ·doi:10.1371/journal.pmed.0050085

BackgroundPancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. The development of molecular mark…